In vitro susceptibility of methicillin-resistant and methicillin-susceptible strains of Staphylococcus aureus to two different cold atmospheric plasma sources
Autor: | Hermann Haase, Denis Gümbel, Romy Spitzmueller, Peter Hinz, Matthias Napp, Michael Jünger, Georg Daeschlein, Steffen Emmert, Richard Kasch, Sebastian von Podewils |
---|---|
Rok vydání: | 2016 |
Předmět: |
Methicillin-Resistant Staphylococcus aureus
Microbiology (medical) Staphylococcus aureus Plasma Gases medicine.drug_class medicine.disease_cause Models Biological 01 natural sciences Microbiology 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Antiseptic In vivo 0103 physical sciences Humans Medicine Pathogen 010302 applied physics business.industry General Medicine biochemical phenomena metabolism and nutrition bacterial infections and mycoses Antimicrobial Methicillin-resistant Staphylococcus aureus In vitro Anti-Bacterial Agents Infectious Diseases Staphylococcal Skin Infections business |
Zdroj: | Infection. 44:531-537 |
ISSN: | 1439-0973 0300-8126 |
DOI: | 10.1007/s15010-016-0888-9 |
Popis: | Staphylococcus aureus may be the most important wound pathogen and causative for most of surgical site infections. As many anti-staphylococcal drugs are useless because of resistance, novel antimicrobial strategies are strongly needed and may be provided by cold atmospheric plasma (CP), which is being currently investigated for antiseptic efficacy. To test the antimicrobial properties of CP against Staphylococcus aureus, 168 methicillin-susceptible isolates (MSSA) and 50 methicillin-resistant isolates (MRSA) were treated with two technically different plasma sources [an atmospheric pressure plasma jet (APPJ) and a dielectric barrier discharge plasma (DBD)] in vitro. CP treatment allowed a reproducible and significant growth reduction of MRSA and MSSA. However, MRSA was significantly less susceptible to treatment with DBD than was MSSA, while no difference between MRSA and MSSA was found using APPJ. As the initial physical antiseptic on skin, CP may be suitable for rapid decolonization of microbial pathogens in vivo. Each device must undergo validated efficacy testing prior to clinical application, as device related differences may occur. |
Databáze: | OpenAIRE |
Externí odkaz: |